Literature DB >> 12084594

Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial.

Richard L Page1, Richard E Kerber, James K Russell, Tom Trouton, Johan Waktare, Donna Gallik, Jeff E Olgin, Philippe Ricard, Gavin W Dalzell, Ramakota Reddy, Ralph Lazzara, Kerry Lee, Mark Carlson, Blair Halperin, Gust H Bardy.   

Abstract

OBJECTIVES: This study compared a biphasic waveform with a conventional monophasic waveform for cardioversion of atrial fibrillation (AF).
BACKGROUND: Biphasic shock waveforms have been demonstrated to be superior to monophasic shocks for termination of ventricular fibrillation, but data regarding biphasic shocks for conversion of AF are still emerging.
METHODS: In an international, multicenter, randomized, double-blind clinical trial, we compared the effectiveness of damped sine wave monophasic versus impedance-compensated truncated exponential biphasic shocks for the cardioversion of AF. Patients received up to five shocks, as necessary for conversion: 100 J, 150 J, 200 J, a fourth shock at maximum output for the initial waveform (200 J biphasic, 360 J monophasic) and a final cross-over shock at maximum output of the alternate waveform.
RESULTS: Analysis included 107 monophasic and 96 biphasic patients. The success rate was higher for biphasic than for monophasic shocks at each of the three shared energy levels (100 J: 60% vs. 22%, p < 0.0001; 150 J: 77% vs. 44%, p < 0.0001; 200 J: 90% vs. 53%, p < 0.0001). Through four shocks, at a maximum of 200 J, biphasic performance was similar to monophasic performance at 360 J (91% vs. 85%, p = 0.29). Biphasic patients required fewer shocks (1.7 +/- 1.0 vs. 2.8 +/- 1.2, p < 0.0001) and lower total energy delivered (217 +/- 176 J vs. 548 +/- 331 J, p < 0.0001). The biphasic shock waveform was also associated with a lower frequency of dermal injury (17% vs. 41%, p < 0.0001).
CONCLUSIONS: For the cardioversion of AF, a biphasic shock waveform has greater efficacy, requires fewer shocks and lower delivered energy, and results in less dermal injury than a monophasic shock waveform.

Entities:  

Mesh:

Year:  2002        PMID: 12084594     DOI: 10.1016/s0735-1097(02)01898-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  24 in total

1.  Importance of using biphasic shock waveforms for cardioversion from atrial fibrillation: an unresolved issue.

Authors:  J M Morgan
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

Review 2.  Theory and practice of defibrillation: (1) Atrial fibrillation and DC conversion.

Authors:  A A J Adgey; S J Walsh
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

3.  [Outcome parameters for AF trials--executive summary of an AFNET-EHRA consensus conference].

Authors:  P Kirchhof; A Goette; G Hindricks; S Hohnloser; K-H Kuck; T Meinertz; U Ravens; G Steinbeck; G Breithardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-12

4.  Synchronised cardioversion for chronic atrail fibrillation.

Authors:  E Aniteye; D Kotei; M Tettey; L Sereboe; F Edwin; A Doku; M Tamatey; K Entsuah-Mensah; S Batista; K Frimpong-Boateng
Journal:  Ghana Med J       Date:  2008-03

5.  Cardioversion: past, present, and future.

Authors:  Ivan Cakulev; Igor R Efimov; Albert L Waldo
Journal:  Circulation       Date:  2009-10-20       Impact factor: 29.690

6.  Rate of conversion and recurrence after sotalol treatment in patients with direct current-refractory atrial fibrillation.

Authors:  Anna Nergärdh; Rolf Nordlander; Mats Frick
Journal:  Clin Cardiol       Date:  2006-02       Impact factor: 2.882

7.  Impedance-gradient electrode reduces skin irritation induced by transthoracic defibrillation.

Authors:  P F Meyer; P D Gadsby; D Van Sickle; W E Schoenlein; K S Foster; G P Graber
Journal:  Med Biol Eng Comput       Date:  2005-03       Impact factor: 2.602

8.  Association between transthoracic impedance and electrical cardioversion success with biphasic defibrillators: An analysis of 1055 shocks for atrial fibrillation and flutter.

Authors:  Mouhannad M Sadek; Varsha Chaugai; Mark J Cleland; Timothy J Zakutney; David H Birnie; F Daniel Ramirez
Journal:  Clin Cardiol       Date:  2018-05-11       Impact factor: 2.882

Review 9.  [Therapy of atrial fibrillation in the critically ill].

Authors:  T Willich; M Hammwöhner; A Goette
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-06-13       Impact factor: 0.840

10.  Present concepts in management of atrial fibrillation: From drug therapy to ablation.

Authors:  Giovanni B Forleo; Luca Santini; Francesco Romeo
Journal:  World J Cardiol       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.